🔗 Share this article

Treasury head Reeves has announced she is preparing "focused action to tackle cost of living challenges" in the upcoming financial statement.

Speaking to the BBC, she noted that reducing inflation is a shared responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Cost Measures

It is understood the government could intervene to reduce energy bills, for instance by cutting the present 5% level of VAT charged on energy supplies.

A further possibility is to reduce some of the government charges presently included in bills.

Fiscal Limitations and Analyst Expectations

The administration will obtain the latest assessment from the official forecaster, the OBR, on Monday, which will show how much scope there is for such measures.

The consensus from the majority of analysts is that the Chancellor will have to announce tax increases or spending cuts in order to meet her voluntary fiscal targets.

Previously on the same day, estimates suggested there was a £22 billion gap for the chancellor to fill, which is at the lower end of projections.

"It is a collective responsibility between the central bank and the administration to continue tackling some of the causes of price increases," Reeves told the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the latest information from the OBR had not changed her pledge to campaign commitments not to increase rates on income tax, sales tax or National Insurance.

She blamed an "uncertain world" with growing geopolitical and trade issues for the fiscal revenue measures, probably to be focused on those "most able to pay."

International Economic Disputes

Referring to worries about the UK's commercial links with China she said: "The UK's security interests invariably are paramount."

Recent statement by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are crucial for advanced tech production led US President Donald Trump to propose an further 100% tariff on goods from China, raising the risk of an full-scale trade war between the two largest economies.

The American finance chief labeled China's decision "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the US offer to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the global economy and generates additional obstacles."

"I believe there are sectors where we should address Chinese policies, but there are also significant prospects to trade with Chinese markets, including financial services and other sectors of the economy. We've got to achieve that equilibrium correct."

The Treasury chief also stated she was cooperating with G7 counterparts "regarding our own essential resources approach, so that we are more independent."

Health Service Medicine Costs and Funding

The Chancellor also acknowledged that the cost the NHS spends on drugs could rise as a result of ongoing talks with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling projects in the United Kingdom, with some attributing the low prices they are getting.

Recently, the government science advisor said the cost the NHS pays for medicines would have to go up to prevent firms and drug research funding leaving the United Kingdom.

The Chancellor stated to media: "We have seen as a result of the cost structure, that drug testing, recent pharmaceuticals have not been offered in the UK in the manner that they are in other EU nations."

"The objective is to ensure that people getting treatment from the NHS are can obtain the top critical drugs in the world. And so we are reviewing this situation, and... looking to secure additional investment into Britain."